Sign in
Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma. Commentary
Journal article   Peer reviewed

Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma. Commentary

R. P Glick, T Lichtor, A Mogharbel, C. A Taylor, E. P Cohen, J. M Piepmeier, L. T Rutka and B. V Zlokovic
Neurosurgery, Vol.41(4), pp.898-907
1997

Abstract

Antineoplastic agents Biological and medical sciences Immunotherapy Medical sciences Pharmacology. Drug treatments

Metrics

1 Record Views

Details